QLGN - Qualigen Therapeutics Inc
3.04
0.030 0.987%
Share volume: 9,693
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.01
0.03
0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 07-02-2024 | 08-14-2023 | 11-14-2023 | 11-14-2024 | 07-02-2024 | 08-14-2024 | 11-14-2024 | |
| Cash flow financing | 0.000 | 0.000 | -440.000 K | -110.000 K | 475.000 K | 1.150 M | 3.319 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 265.981 K | |
| Cash flow | -2.832 M | 0.000 | 4.717 M | -5.546 M | -308.586 K | 25.468 K | 269.467 K | |
| Net income | -4.107 M | -3.508 M | -3.695 M | 0.000 | -2.033 M | -1.577 M | -1.794 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 4.495 K | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -198.009 K | -48.409 K | 4.227 M | 235.402 K | 0.000 | 350.000 K | -1.250 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -2.832 M | -2.977 M | 4.717 M | -5.546 M | -308.586 K | 25.468 K | 269.467 K |